Bajaj Finserv Healthcare Fund Direct Growth

Bajaj Finserv Healthcare Fund Direct Growth

1M
6M
1Y
All
NAV: 20 Mar '26
₹9.35
Min. for SIP
₹500
Fund size
₹314.74 Cr
Expense ratio
0.74%

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
3 months₹15,000₹15,205
+1.37%
6 months₹30,000₹31,735
+5.78%

Holdings (37)

NameSectorInstrumentsAssets
Divi's Laboratories Ltd.HealthcareEquity9.21%
Sun Pharmaceutical Industries Ltd.HealthcareEquity8.40%
Apollo Hospitals Enterprise Ltd.HealthcareEquity6.80%
Piramal Pharma Ltd.HealthcareEquity6.21%
Aurobindo Pharma Ltd.HealthcareEquity5.93%
Torrent Pharmaceuticals Ltd.HealthcareEquity5.46%
Max Healthcare Institute Ltd.HealthcareEquity4.40%
Emcure Pharmaceuticals Ltd.HealthcareEquity3.79%
Rubicon Research Ltd.HealthcareEquity3.70%
Fortis Healthcare Ltd.HealthcareEquity3.60%
Neuland Laboratories Ltd.HealthcareEquity3.40%
Lupin Ltd.HealthcareEquity2.65%
Ipca Laboratories Ltd.HealthcareEquity2.45%
Zydus Wellness Ltd.Consumer StaplesEquity2.00%
Navin Fluorine International Ltd.ChemicalsEquity1.99%
Sanofi Consumer Healthcare India Ltd.HealthcareEquity1.98%
Vijaya Diagnostic Centre Ltd.HealthcareEquity1.97%
Glaxosmithkline Pharmaceuticals Ltd.HealthcareEquity1.94%
Godrej Consumer Products Ltd.Consumer StaplesEquity1.93%
Glenmark Pharmaceuticals Ltd.HealthcareEquity1.88%
Bajaj Finserv Money Market Fund Direct-Growth--Mutual Fund1.62%
Dr. Lal Pathlabs Ltd.HealthcareEquity1.57%
Shaily Engineering Plastics Ltd.ChemicalsEquity1.54%
Abbott India Ltd.HealthcareEquity1.46%
Biocon Ltd.HealthcareEquity1.42%
Medplus Health Services Ltd.HealthcareEquity1.39%
Krishna Institute of Medical Sciences LtdHealthcareEquity1.18%
Medi Assist Healthcare Services Ltd.ServicesEquity1.18%
Hindustan Unilever Ltd.Consumer StaplesEquity1.16%
Tata Consumer Products Ltd.Consumer StaplesEquity1.09%
Eris Lifesciences Ltd.HealthcareEquity1.08%
Cipla Ltd.HealthcareEquity1.02%
Jubilant Pharmova Ltd.HealthcareEquity0.96%
Emami Ltd.Consumer StaplesEquity0.95%
Astrazeneca Pharma India Ltd.HealthcareEquity0.92%
Alembic Pharmaceuticals Ltd.HealthcareEquity0.90%
Kwality Wall's (India) Ltd.Consumer StaplesEquity0.01%
See All

Minimum investments

Min. for 1st investment
₹500
Min. for 2nd investment
₹100
Min. for SIP
₹500

Returns and rankings

Annualised returns
Absolute returns
Name3M6M1YAll
Fund returns-5.1%-6.7%+7.4%-6.2%
Category average (Equity Sectoral)-----2.1%--
Rank (Equity Sectoral)221813--

Exit load, stamp duty and tax

Exit load

1% for redemption within 3 Months

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.

Fund management

About Bajaj Finserv Healthcare Fund Direct Growth

Bajaj Finserv Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Bajaj Finserv Mutual Fund. This scheme was made available to investors on 18 Oct 2021. Nimesh Chandan is the Current Fund Manager of Bajaj Finserv Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹33,148 Cr and the Latest NAV as of 20 Mar 2026 is ₹9.35. The Bajaj Finserv Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹500. Minimum Lumpsum Investment is ₹500. 1% for redemption within 3 Months ;

Investment Objective

The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)--
Total AUM₹33,148.49 Cr
Date of Incorporation18 Oct 2021
Phone--
E-mail--
Launch Date18 Oct 2021
AddressS. No - 239/2, 11th Floor, Office No. 1101 A and 1101 B,Sky One Corporate Park, Lohegaon, Pune, Maharashtra Pune 411032
CustodianDeutsche Bank
Registrar & Transfer AgentKFin Tech
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,